T cells are chief participants in adaptive immune responses to invading pathogens. After antigen engagement, the T cell antigen receptor (TCR) signals the activation of T cells together with signals delivered by costimulatory molecules, most notably CD28 (ref. 1) . Activated CD4 + and CD8 + T cells differentiate into various effector T cells that participate in pathogen clearance either directly or indirectly by providing help for the activation of other cells of the immune response. In contrast to their efficient response to foreign antigens, T cells are normally tolerant to antigens of self tissues, which prevents the development of autoimmunity 2 . The tolerance of cells to self antigens is controlled by various mechanisms. In addition to the developmental deletion or inactivation of autoreactive T cells by mechanisms of central tolerance 2 , peripheral T cells are tightly controlled by both extrinsic and intrinsic factors 3 . Among the extrinsic factors, regulatory T cells (T reg cells) suppress the activation of naive T cells through both physical interaction and the secretion of immunosuppressive cytokines, such as transforming growth factor-β (TGF-β) and interleukin 10 (IL-10) [4] [5] [6] [7] . Intrinsic factors include various molecules that negatively regulate the TCR and CD28 signals 8 . Thus, autoimmunity may occur due to either defects in T reg cells or impaired negative regulation of TCR-CD28 signaling.
Several negative regulators of TCR-proximal signaling have been described 9 , although relatively less is known about the regulation of downstream signaling events. A critical downstream signaling event triggered by TCR-CD28 signaling is activation of the NF-κB pathway, a family of transcription factors required for the activation and differentiation of T cells 10, 11 . The mammalian NF-κB family is composed of five members, RelA, RelB, c-Rel, p50 and p52, which form various dimeric complexes and transactivate target genes by binding to the enhancer element κB. In resting T cells, NF-κB proteins are sequestered in the cytoplasm by the inhibitory IκB proteins. The canonical pathway of NF-κB activation involves phosphorylation of IκBα by IκB kinase (IKK) and subsequent degradation of IκBα, which triggers the nuclear translocation of NF-κB dimers. An important NF-κB family member involved in T cell activation is c-Rel, which mediates the cytokine production, proliferation and differentiation of T cells [12] [13] [14] [15] [16] [17] . Deficiency in c-Rel renders T cells more susceptible to tolerance induction 18 . In contrast to the rapid and transient nature of RelA activation, induction of the nuclear translocation of c-Rel is delayed and more persistent and is critically dependent on CD28 costimulation [19] [20] [21] . Although RelA is subject to tight control by IκBα-mediated feedback regulation, the negative regulation of c-Rel activation has remained unclear.
Ubiquitination has emerged as a critical mechanism that regulates T cell activation 9, 22 . The Cbl family of ubiquitin ligases mediates Lys48 (K48) ubiquitination and degradation of TCR-proximal signaling factors, thereby negatively regulating T cell activation 23, 24 . However, ubiquitin ligases that catalyze K63-linked ubiquitin chains mediate IKK activation and positively regulate NF-κB signaling 22 . An additional family of E3 ligases, the Peli (Pellino) family, has been shown to catalyze the formation of both K63 and K48 ubiquitin chains [25] [26] [27] . The mammalian Peli family is composed of three members, Peli1, Peli2 and Peli3, that share strong sequence homology and structural domains 28, 29 . The E3 ubiquitin ligase function of Peli T cell activation is subject to tight regulation to avoid inappropriate responses to self antigens. Here we show that genetic deficiency in the ubiquitin ligase Peli1 caused hyperactivation of T cells and rendered T cells refractory to suppression by regulatory T cells and transforming growth factor-b (TGF-b). As a result, Peli1-deficient mice spontaneously developed autoimmunity characterized by multiorgan inflammation and autoantibody production. Peli1 deficiency resulted in the nuclear accumulation of c-Rel, a member of the NF-kB family of transcription factors with pivotal roles in T cell activation. Peli1 negatively regulated c-Rel by mediating its Lys48 (K48) ubiquitination. Our results identify Peli1 as a critical factor in the maintenance of peripheral T cell tolerance and demonstrate a previously unknown mechanism of c-Rel regulation.
A r t i c l e s proteins is dependent on their C-terminal RING domain [25] [26] [27] . In vitro studies suggest that Peli proteins interact with the kinase IRAK1 and mediate activation of NF-κB and mitogen-activated protein kinases via Toll-like receptors (TLRs) and the IL-1 receptor (IL-1R) 28, 29 . In addition, Peli1 has an essential role in mediating the activation of NF-κB via TLRs dependent on the adaptor TRIF, such as TLR3 and TLR4, although Peli1 is dispensable for the activation of NF-κB by TLRs dependent on the adaptor MyD88 and by IL-1R 30 . As Peli1 has both K63 and K48 E3 ligase activities, whether it mediates distinct biological functions remains unknown.
Here we describe a previously unknown function for Peli1 in the regulation of T cell activation and homeostasis. We found that Peli1 served as a critical negative regulator of T cell activation and prevented the development of autoimmunity. This function of Peli1 was mediated through targeting of c-Rel for K48 ubiquitination and degradation. Peli1 deficiency did not affect the activation of IKK but caused the nuclear accumulation of c-Rel in activated T cells. Consequently, Peli1-deficient T cells were hyper-responsive to stimulation via TCR-CD28, and Peli1-deficient mice developed autoimmunity. Our data establish Peli1 as a critical factor that controls T cell homeostasis and peripheral tolerance and highlight a previously unknown mechanism for the regulation of c-Rel. As Peli1 does not effect upstream TCR signaling, it may be exploited as a therapeutic target for manipulating T cell responses.
RESULTS

Peli1 is a negative regulator of T cell activation
As an approach for assessing the physiological functions of Peli1, we searched for its expression profile in the BioGPS database. Lymphocytes had abundant expression of Peli1, and neither Peli2 nor Peli3 had such an expression pattern. Real-time RT-PCR confirmed the abundant expression of Peli1 in lymphocytes, particularly T cells ( Supplementary Fig. 1a ). Furthermore, Peli1 was induced along with the activation of T cells by agonistic antibody to CD3 (anti-CD3) and anti-CD28 ( Supplementary Fig. 1b,c) .
To assess the function of Peli1 in T cell activation, we stimulated wild-type (Peli1 +/+ ) and Peli1-deficient (Peli1 −/− ) T cells in vitro with anti-CD3 and anti-CD28. In contrast to its positive role in TRIF-dependent TLR signaling 30 , Peli1 had a potent negative function in T cell activation. The Peli1 −/− CD4 + T cells were hyper-responsive to stimulation with anti-CD3 and anti-CD28, as shown by their enhanced production of the major T cell cytokines IL-2 and interferon-γ ( Fig. 1a) . This phenotype was even more notable in Peli1 −/− CD8 + T cells ( Fig. 1b) . In response to activation with either anti-CD3 and anti-CD28 or T cell mitogens (the phorbol ester PMA plus the calcium ionophore ionomycin), Peli1 −/− CD8 + T cells produced more IL-2 and interferon-γ than did wild-type CD8 + T cells ( Fig. 1b,c) . Moreover, we also readily detected the hyper-responsive phenotype in purified naive Peli1 −/− T cells ( Fig. 1d and data not shown).
We examined T cell proliferation by assessing dilution of the cytosolic dye CFSE. Both total and naive Peli1 −/− CD8 + T cells had markedly enhanced proliferation ability ( Supplementary Fig. 2a,b) . Notably, loss of Peli1 rendered T cells able to respond to TCR stimulation in the absence of ligation of CD28 by anti-CD28. Whereas wild-type T cells were only weakly stimulated by low doses of anti-CD3, Peli1 −/− T cells had considerable proliferation ability even when stimulated with low doses of anti-CD3. The effect of Peli1 deficiency on the proliferation of CD4 + T cells was less prominent (data not shown). Together these results demonstrate a critical role for Peli1 in the negative regulation of T cell activation.
Peli1 deficiency causes spontaneous activation of T cells in vivo
To assess the role of Peli1 in regulating T cell homeostasis in vivo, we analyzed the activation status of CD4 + T cells and CD8 + T cells on the basis of their surface expression of the activation markers CD44 and CD62L. In wild-type mice, most T cells isolated from the spleen were in a naive state, characterized by a CD44 lo CD62L hi phenotype ( Fig. 2a ). Peli1 −/− mice did not have an obvious abnormality in the frequency of naive and memory T cells at an young age (5-8 weeks; data not shown) and had only slightly more memory CD44 hi CD62L lo T cells at an older age (10 weeks; Fig. 2a ). However, at 6 months of age or older, Peli1 −/− mice had a higher frequency of memory T cells and concomitant fewer naive T cells in the spleen ( Fig. 2a,b) . We detected a similar phenotype in peripheral lymph nodes ( Supplementary  Fig. 3 ), although it was moderate in the mesentery lymph nodes (Supplementary Fig. 3 ). The absolute number of memory T cells was also higher in the spleen and peripheral lymph nodes of Peli1 −/− mice ( Supplementary Fig. 4) . These results suggest that Peli1 has a critical role in maintaining the homeostasis of T cells in vivo, in line with the in vitro hyper-responsiveness of Peli1-deficient T cells.
Peli1 is a T cell-intrinsic regulator of activation
To determine whether the role of Peli1 in T cell regulation is cell intrinsic, we did experiments using adoptive transfer of mixed bone marrow. Under such experimental conditions, wild-type and Peli1 −/− T cells develop and are maintained homeostatically in the same 1 0 0 4 VOLUME 12 NUMBER 10 OCTOBER 2011 nature immunology A r t i c l e s in vivo environment. At 10 weeks after adoptive transfer of mixed bone marrow, we analyzed the frequency of memory and naive T cells derived from wild-type and Peli1 −/− bone marrow. Peli1 −/− T cell populations had more memory T cells (CD44 hi CD62L lo ) and concomitantly fewer naive T cells (CD44 lo CD62L hi ) than did their wildtype counterparts (Fig. 2c) . We detected this phenotype in various peripheral lymphoid organs, including the peripheral lymph nodes ( Fig. 2c) , spleen (Supplementary Fig. 5a ) and mesenteric lymph nodes ( Supplementary Fig. 5b ). Therefore, Peli1 has a T cell-intrinsic role in the negative regulation of T cell activation.
Peli1 −/− T cells are refractory to suppression by T reg cells and TGF-b
As T reg cells have a critical role in maintaining peripheral T cell tolerance, we sought to determine whether Peli1 influences the development of T reg cells. We analyzed the frequency of T reg cells in the thymus and the peripheral lymphoid organs (spleen and lymph nodes) on the basis of their expression of the transcription factor Foxp3 and their surface expression of CD4 and CD25. Peli1 −/− mice did not have a lower frequency of T reg cells ( Fig. 3a) . We detected a slightly higher frequency of T reg cells in both the thymus and the peripheral lymphoid organs of young Peli1 −/− mice ( Fig. 3a,b ). This phenotype became more prominent in older Peli1 −/− mice (6 months; Fig. 3b ), probably due to the greater frequency of memory T cells in the mutant mice. Notwithstanding that finding, these results suggest that Peli1 deficiency does not cause a defect in T reg cell development.
The strength of TCR-CD28 signaling affects the sensitivity of target T cells to suppression by T reg cells 5 . Because Peli1 −/− T cells were hyper-responsive to TCR-CD28 stimulation ( Fig. 1) , we determined whether the mutant T cells were more resistant to T reg cell-mediated suppression. We activated naive wild-type and Peli1 −/− CD4 + T cells in the presence of increasing numbers of T reg cells derived from wild-type mice and measured the proliferation of the target T cells on the basis of CFSE dilution. As expected, the proliferation of wild-type CD4 + T cells was suppressed by the T reg cells in a dose-dependent manner (Fig. 3c) , whereas Peli1 −/− T cells were less sensitive to T reg cell-mediated suppression (Fig. 3c ). In contrast, loss of Peli1 did not affect the effector function of T reg cells (Supplementary Fig. 6 ).
Because T reg cells are known to inhibit target cell activation by secreting TGF-β 31,32 , we examined the effect of TGF-β on T cell activation mediated by anti-CD3 and anti-CD28. TGF-β effectively suppressed the activation of wild-type T cells ( Fig. 3d) , whereas under the same conditions, Peli1 −/− T cells were much less susceptible to TGF-β-mediated suppression (Fig. 3d) . This phenotype was particularly prominent for CD8 + T cells, although we also detected it in CD4 + T cells (64% inhibition of Peli1 −/− CD4 + T cells and 87% inhibition of wild-type CD4 + T cells; Fig. 3d ).
Peripheral T cell tolerance also involves the induction of anergy, as a result of TCR stimulation in the absence of costimulation 33 . We investigated the role of Peli1 in regulating T cell anergy through the use of a well-characterized in vivo model of oral tolerance. We crossed wildtype and Peli1 −/− mice to transgenic mice expressing the ovalbumin (OVA)-specific TCR OT-II and induced T cell tolerance by feeding the progeny OVA peptide. As expected, OVA peptide induced T cell anergy in wild-type OT-II mice, as indicated by a 37.1% inhibition of antigen-stimulated T cell proliferation ( Fig. 3e ). Peli1 deficiency resulted in less induction of T cell anergy (14.4% inhibition), although it did not completely block this (Fig. 3e) . Collectively, these data suggest that Peli1 deficiency renders CD4 + T cells and CD8 + T cells less susceptible to suppression by T reg cells and TGF-β as well as to anergy induction, a phenotype that has also been observed for T cells lacking some other negative regulators of T cell activation 5, 34, 35 .
Peli1 −/− mice spontaneously develop autoimmunity As abnormal activation of T cells is often associated with autoimmunity, we assessed the autoimmune phenotype of Peli1 −/− mice. The peripheral lymph nodes of Peli1 −/− mice were enlarged as early as 10 weeks of age ( Fig. 4a) showed moderate splenomegaly (Supplementary Fig. 7) . Moreover, old Peli1 −/− mice had more cellularity in the spleen and peripheral lymph nodes, although this phenotype was moderate in mesenteric lymph nodes (Fig. 4b) . Histological analysis detected considerable infiltration of cells of the immune response into many organs, including kidney, liver and lung (Fig. 4c) . Both CD4 + T cells and CD8 + T cells were readily detected by immunohistochemistry in the inflammatory lesions of Peli1 −/− mice (Fig. 4d) , and the lesions also contained B220 + B cells (Supplementary Fig. 8 ). These results are typical of autoimmune diseases associated with aberrant T cell responses. To further examine the autoimmune status of the Peli1 −/− mice, we investigated the presence of serum autoantibodies and deposition of immune complexes in kidney glomeruli. Peli1 −/− mice had significantly higher concentrations of antinuclear antibodies in the serum (Fig. 4e) and also showed considerable deposition of immune complexes in the kidney glomeruli ( Fig. 4f) .
We also investigated the role of Peli1 in inducible autoimmunity through the use of experimental autoimmune encephalomyelitis (EAE) as a model. To avoid a contribution from cells of the innate immune response, which also express Peli1, we induced EAE via the transfer of wild-type and Peli1 −/− T cells into mice deficient in recombination-activating gene 1. Consistent with their hyperresponsive phenotype, Peli1 −/− T cells induced EAE with much higher disease scores than did wild-type T cells (Supplementary Fig. 9a ). Consistent with that, Peli1 −/− T cells produced a much higher frequency of inflammatory IL-17-producing helper T cells and T helper type 1 cells (Supplementary Fig. 9b) . These findings suggest that Peli1 has an important role in preventing T cell-mediated autoimmunity.
Peli1 deficiency causes hyperactivation of late-phase NF-kB
To obtain molecular insight into the function of Peli1, we analyzed the effects Peli1 deficiency on TCR-and CD28-stimulated signaling events. We purified T cells from young wild-type and Peli1 −/− mice (5-8 weeks of age) because at such a young age they did not show differences in the frequency of memory and naive T cells (data not shown). The activation of NF-κB by anti-CD3 or by anti-CD3 plus anti-CD28 was much greater in Peli1 −/− T cells (Fig. 5a) . We noticed that the hyperactivation of NF-κB in Peli1 −/− T cells was particularly evident at the late time point of cell stimulation, whereas during the early phase, loss of Peli1 had no obvious effect on the activation of NF-κB ( Fig. 5b-d) . Furthermore, in contrast to the hyperactivation of NF-κB, the activation of another T cell transcription factor, AP-1, was largely normal (Fig. 5b) , which suggested a specific role for Peli1 in the control of the NF-κB pathway. We obtained similar results with purified CD4 + T cells and CD8 + T cells ( Fig. 5c and data not shown). Of note, we also saw hyperactivation of NF-κB in Peli1 −/− T cells stimulated with the T cell mitogens PMA and ionomycin (Fig. 5c) , which are known to activate the protein kinase C and calcium pathways independently of the TCR-proximal signaling steps; this suggested that Peli1 might not affect TCR-proximal signaling. To exclude the possibility that the enhanced activation of NF-κB in Peli1 −/− T cells was due to the presence of more memory T cells, we repeated the experiment with sorted naive T cells (Fig. 5d) . As with total T cells, Peli1 deficiency promoted delayed activation of NF-κB without appreciably altering the early phase NF-κB activation.
To understand how Peli1 negatively regulates NF-κB activation, we examined the effect of Peli1 deficiency on the activation of IKK, the 1 0 0 6 VOLUME 12 NUMBER 10 OCTOBER 2011 nature immunology A r t i c l e s kinase that mediates the activation of NF-κB. Peli1 −/− T cells did not show more activation of IKK in response to T cell mitogens (Fig. 5e) . Moreover, we detected slightly less activation of IKK in Peli1 −/− T cells (Fig. 5e) . Peli1 deficiency did not promote mitogen-stimulated activation of the mitogen-activated protein kinase Erk (Fig. 5e ). In addition, after crosslinking the TCR and CD28, we did not detect appreciable differences in activation of the tyrosine kinase Zap70 or Erk ( Supplementary  Fig. 10 ). Together with the predominant effect of Peli1 deficiency on late-phase activation of NF-κB, these findings suggest that Peli1 may specifically regulate a downstream step in NF-κB activation.
Loss of Peli1 selectively promotes activation of c-Rel
It is known that c-Rel is a late-phase NF-κB protein activated in T cells 19 and is crucial for the induction of genes involved in the activation and differentiation of T cells as well as in the prevention of T cell anergy 12, 14, 16, 36 . An antibody supershift assay showed abundant c-Rel in the late-phase NF-κB complex (Fig. 6a) . We thus examined the effect of Peli1 deficiency on the nuclear expression of c-Rel and other members of the NF-κB family stimulated via the TCR plus CD28. Peli1 −/− T cells had much more nuclear c-Rel than did the control wild-type T cells (Fig. 6b) . In contrast to their c-Rel content, wild-type and Peli1 −/− T cells had similar amounts of nuclear RelA and RelB (Fig. 6c) . We also found hyperactivation of c-Rel in Peli1 −/− T cells stimulated with PMA and ionomycin (Fig. 6c) . Moreover, we detected this phenotype in purified CD4 + T cells and CD8 + T cells ( Fig. 6c and data not shown) as well as in naive T cells (Fig. 6d) .
To address whether the phenotype detected was directly caused by the loss of Peli1, we knocked down Peli1 in the EL4 mouse lymphoma T cell line through the use of short hairpin RNA. As seen in primary T cells (Supplementary Fig. 1c) , untreated EL4 cells had little Peli1, but it was induced considerably in response to mitogen stimulation (Fig. 6e) . Moreover, knockdown of Peli1 led to considerable enhancement of c-Rel activation (Fig. 6f) , whereas overexpression of Peli1 in EL4 cells inhibited the activation of c-Rel ( Fig. 6g) . Of note, modulation of c-Rel activation required the C-terminal RING domain of Peli1, as a mutant lacking this region (Peli1∆C) did not inhibit the activation of c-Rel (Fig. 6g) . Collectively, these results demonstrate a role for Peli1 in regulating the activation of c-Rel by signals from TCR and CD28.
Peli1 mediates K48 ubiquitination of c-Rel
A published study has reported that c-Rel undergoes ubiquitination and degradation in leukemia T cell lines with constitutive NF-κB signaling 37 . To determine whether signals from the TCR plus CD28 induce the ubiquitination of c-Rel and whether this event is regulated by Peli1, we stimulated T cells with anti-CD3 and anti-CD28 and then incubated them with the proteasome inhibitor MG132 to block degradation of ubiquitinated c-Rel. In wild-type T cells, c-Rel was ubiquitinated in response to stimulation of the TCR plus CD28 (Fig. 7a) . Because we detected the accumulation of ubiquitinated 1 0 0 8 VOLUME 12 NUMBER 10 OCTOBER 2011 nature immunology A r t i c l e s c-Rel only in the presence of the proteasome inhibitor MG132, it is likely that c-Rel undergoes ubiquitin-dependent degradation in activated T cells. However, the induction of c-Rel ubiquitination was largely blocked in Peli1 −/− T cells (Fig. 7a) . These results suggest the involvement of ubiquitination in the regulation of c-Rel during normal T cell activation and establish Peli1 as an essential E3 ligase that mediates c-Rel regulation. We further determined if a physical interaction occurred between Peli1 and c-Rel. Endogenous Peli1 and c-Rel were precipitated together by anti-Peli1 but not by preimmune serum (Fig. 7b) , which suggested that the two proteins interact in T cells. We detected stronger binding of c-Rel to Peli1 in T cells stimulated with anti-CD3 plus anti-CD28, probably because they contained more c-Rel and Peli1 protein. In HEK293T human embryonic kidney cells transfected with vectors expressing the two proteins, Peli1 bound to c-Rel, and the C-terminal RING domain of Peli1 was dispensable for this association ( Fig. 7c  and Supplementary Fig. 11) . Moreover, Peli1 expression in HEK293T cells led to potent induction of c-Rel ubiquitination (Fig. 7d) . As the ubiquitin ligase function of Peli1 required its C-terminal RING domain, the Peli1∆C mutant largely lost its ability to induce c-Rel ubiquitination (Fig. 7d) despite its ability to bind c-Rel (Fig. 7c) . We obtained similar results with the EL4 T cell line ( Supplementary  Fig. 12) . The defective c-Rel ubiquitination by Peli1∆C was consistent with the inability of Peli1∆C to inhibit c-Rel activation (Fig. 6g) .
As Peli1 is able to catalyze both K48-and K63-linked ubiquitin chains 26 , we determined whether Peli1-induced ubiquitination of c-Rel involved K63-or K48-linked ubiquitination chains. For this, we used ubiquitin mutants with a lysine-to-arginine substitution at Lys63 (K63R) or Lys48 (K48R). Whereas the K63R ubiquitin mutant was able to mediate Peli1-stimulated ubiquitination of c-Rel, the K48R ubiquitin mutant was defective in this modification (Fig. 7e) . This result was not due to differences in the expression of these ubiquitin mutants (Fig. 7f) . Thus, Peli1 induces the K48-ubiquitination and degradation of c-Rel in activated T cells.
DISCUSSION
The Peli proteins are regulators of signaling via IL-1R and TLR 28, 29 . Peli1 has a critical role in regulating IKK activation by TRIFdependent TLR signaling, although it is largely dispensable for IKK activation by IL-1R and the MyD88-dependent TLRs 30 . Here we have shown that Peli1 is unique because of its high expression in lymphocytes and its important role in the negative regulation of T cell activation and maintenance of peripheral immune tolerance. In contrast to its role in TLR signaling, Peli1 was largely dispensable for activation of IKK by TCR signals but it did mediate the ubiquitination and degradation of c-Rel. Peli1-deficient T cells were hyper-responsive to stimulation via the TCR and CD28 in vitro and had an activated phenotype in vivo, and Peli1 −/− mice developed signs of severe autoimmune disease. Although published work has suggested constitutive ubiquitination of c-Rel in transformed T cell lines 37 , whether this event occurs inducibly during normal T cell activation has remained unknown. Our work has not only identified Peli1 as a c-Rel ubiquitin ligase but also demonstrated ubiquitin-dependent degradation of c-Rel as a mechanism for the negative regulation of T cell activation.
The opposing functions of Peli1 in TLR and TCR signaling pathways are notable. However, similar functions have been reported for another E3 ubiquitin ligase, TRAF6. Like Peli1, TRAF6 functions as a negative regulator in T cells but has a positive role in regulating TLR signaling 35 . Precisely how TRAF6 negatively regulates T cell activation is unclear, but TRAF6-deficient T cells have more activation of the kinase Akt 35 . Our study has shown that the negative role of Peli1 in T cell activation was not due to hyperactivation of IKK but instead involved the accumulation of the specific NF-κB protein c-Rel. Our data suggest that Peli1 mediates K48 ubiquitination of c-Rel, in agreement with published studies showing that Peli1 can catalyze both K48-and K63-linked ubiquitin chains 26 . Dual specificity in ubiquitin-chain conjugation has been reported for several other E3 ubiquitin ligases, such as SCFβ TrCP , c-IAP1 and c-IAP2, and Parkin [38] [39] [40] [41] . It remains to be investigated whether Peli1 mediates the K48 ubiquitination of additional targets.
T cell activation requires both TCR and CD28 costimulatory signals, and stimulation of naive T cells in the absence of the CD28 signal leads to T cell anergy 33 . Accumulating evidence suggests that c-Rel is a critical factor that integrates the TCR and CD28 signals and mediates T cell activation. Activation of c-Rel is strictly dependent on the CD28 signal 19, 20 , and c-Rel is a major transcription factor that binds to the CD28-responsive element in the promoter region of the genes encoding IL-2 and other T cell cytokines 19, 42, 43 . Indeed, c-Rel is required for both the initial activation and subsequent differentiation of T cells [12] [13] [14] 17, 36 . Moreover, c-Rel deficiency renders T cells sensitive to tolerance induction and prevents the development of autoimmune inflammation 14, 18, 36 . Consistent with those studies, we found that hyperactivation of c-Rel in Peli1 −/− T cells was associated with aberrant T cell activation. In contrast to the requirement for costimulation via TCR and CD28 for normal T cell activation, Peli1 −/− T cells were activated by the TCR signal in the absence of costimulation via CD28. Thus, Peli1, probably by regulating the magnitude of c-Rel activation, controls the threshold of T cell response and maintains the requirement for CD28 costimulation, a mechanism that may contribute to the prevention of autoimmunity.
We found that Peli1-deficient naive T cells were less susceptible than control T cells to T reg cell-mediated suppression. These mutant T cells also showed considerable resistance to TGF-β-mediated suppression. This functional phenotype may have been due to the hyperactivation of Peli1-deficient T cells, as similar phenotypes have been noted for T cells lacking other negative regulators 34, 35 . T cells with hyperactive NF-κB, because of their lack of the IκB-like molecule p105, are also resistant to T reg cell-mediated suppression 44 . It is thus likely that hyperactivation of c-Rel contributed to the resistance of Peli1 −/− T cells to T reg cell-and TGF-β-mediated suppression. Of course, our data do not exclude the possibility that Peli1 is involved in an additional mechanism of T cell regulation.
In summary, we have shown that the E3 ubiquitin ligase Peli1 is an additional negative regulator of T cell activation that contributes to the maintenance of peripheral T cell tolerance. Our data suggest that Peli1 mediates the K48 ubiquitination of c-Rel, which seems to prevent aberrant accumulation of this key NF-κB factor during T cell activation. This finding is in line with its abundant expression in T cells. Thus, despite their structural homology, members of the Peli family have nonredundant functions, probably due to their different profiles of expression. Our findings further emphasize the importance of E3 ubiquitin ligases in the regulation of immunotolerance and establish Peli1 as a potential therapeutic target in the treatment of immunological disorders.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
